Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 05 Oct 2026 for METLIFE INC, €45k. Read the official filing
Filing timeline
BuySaleDiana Mckenzie
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
Closed purchases
Market purchases
1
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -67.2%Entry US$56.00 · Close at T+365 US$18.38
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Diana Mckenzie: trading record in brief
Filings by Diana Mckenzie span 4 companies, the busiest being Metlife Inc, Agilon Health, Inc. and Vertex Pharmaceuticals INC / MA. Over a trading history stretching from 1 May 2021 to 1 October 2026, the count stands at 56 filings.
The open-market record is one-sided, with 1 purchase worth €27k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 52 share grants.
On 5 October 2026 came the latest disclosure, a share grant for €45k in Metlife Inc. The latest purchase dates back some time: it was published 676 days ago, on 11 December 2024. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Diana Mckenzie
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations56 total
544 shares@ US$94.350.0001% mcap4.6% of flowCommon StockSEC:0001754648-26-000015:0
157 shares@ US$95.501.4% of flowCommon StockSEC:0001754648-26-000013:0
721 shares@ US$71.174.7% of flowCommon StockSEC:0001754648-26-000007:0
189 shares@ US$70.601.2% of flowCommon StockSEC:0001754648-26-000005:0
639 shares@ US$80.324.6% of flowCommon StockSEC:0001754648-26-000003:0
166 shares@ US$77.821.2% of flowCommon StockSEC:0001754648-25-000006:0
534 shares@ US$81.934.0% of flowCommon StockSEC:0001754648-25-000004:0
158 shares@ US$79.291.1% of flowCommon StockSEC:0001099219-25-000216:0
562 shares@ US$77.854.0% of flowCommon StockSEC:0001099219-25-000179:0
153 shares@ US$79.431.1% of flowCommon StockSEC:0001099219-25-000158:0
78,724 shares0Common StockSEC:0001628280-25-028721:0
796 shares0Common StockSEC:0000875320-25-000182:0
540 shares@ US$81.164.3% of flowCommon StockSEC:0001099219-25-000111:0
144 shares@ US$78.451.1% of flowCommon StockSEC:0001099219-25-000094:0
535 shares@ US$81.784.5% of flowCommon StockSEC:0001099219-25-000026:0
132 shares@ US$82.741.1% of flowCommon StockSEC:0001099219-24-000284:0
12,500 shares@ US$2.2779100.0% of flowCommon StockSEC:0001628280-24-050832:0
Canonical exit: 23 Feb 2025 (T+90)
535 shares@ US$81.784.2% of flowCommon StockSEC:0001099219-24-000243:0
141 shares@ US$74.631.0% of flowCommon StockSEC:0001099219-24-000223:0
627 shares@ US$69.864.3% of flowCommon StockSEC:0001099219-24-000185:0
146 shares@ US$69.061.0% of flowCommon StockSEC:0001099219-24-000161:0
32,119 shares0Common StockSEC:0001628280-24-026128:0
1,001 shares0Common StockSEC:0000875320-24-000127:0
594 shares@ US$73.694.3% of flowCommon StockSEC:0001099219-24-000118:0
129 shares@ US$71.900.9% of flowCommon StockSEC:0001099219-24-000090:0
25 of 56 declarations
